COMMUNIQUÉS West-GlobeNewswire

IBA Reports Half Year 2024 Results

29/08/2024 - 07:00

GROUP REVENUES UP 21.9% ACCELERATED BACKLOG CONVERSION IN PROTON THERAPY AND OTHER ACCELERATORS STRONG GROSS MARGIN IMPROVEMENT AND BREAKEVEN REBIT Louvain-la-Neuve, Belgium, 29 August 2024 - IBA (Ion Beam Applications [...]

IBA publie ses résultats du premier semestre 2024

29/08/2024 - 07:00

REVENUS DU GROUPE EN HAUSSE DE 21,9% ACCELERATION DE LA CONVERSION DU CARNET DE COMMANDES EN PROTONTHÉRAPIE ET AUTRES ACCELERATEURS FORTE AMELIORATION DE LA MARGE BRUTE ET REBIT À L’EQUILIBRE Louvain-La-Neuve, Belgique [...]

Le KFSHRC fait progresser la diversité et l’inclusion dans l’enseignement médical

29/08/2024 - 06:43

RIYADH, Arabie saoudite, 29 août 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (« KFSHRC ») réaffirme son engagement en faveur de l’inclusivité et de la diversité dans l’enseignement [...]

Range Impact Announces Sale of Non-Core Assets as Part of Strategic Plan

29/08/2024 - 03:40

CLEVELAND, OHIO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to improving the health and wellness of people and the planet through a [...]

Hydreight Reports Record Topline¹ Revenue of $5.59M in Q2-2024 (YOY Increase of 27%) and positive Adjusted EBIDTA¹

29/08/2024 - 01:32

“We had another outstanding quarter with record revenue and positive Adjusted EBITDA...Our focus in 2024 is to continue growing revenue, being a profitable company and introducing our story to more potential [...]

Mesoblast Reports Financial Results and Operational Update for Fiscal Year Ended June 30, 2024

29/08/2024 - 01:27

Potential first product approval and preparing for commercial launch NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory [...]

Avicanna Announces Closing of Non-Brokered Private Placement

29/08/2024 - 00:15

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, Aug. 28 [...]

Metagenomi to Participate in Upcoming Investor Conferences

29/08/2024 - 00:10

EMERYVILLE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing [...]

UPDATE: Justin Baldoni’s sports doctor, Dr. Adeel Khan available to comment on treating actor/director’s old sports injuries with groundbreaking regenerative therapy

28/08/2024 - 23:55

MISSISSAUGA, Ontario, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Dr. Adeel Khan, who treated Justin Baldoni for back pain and herniated disks using cutting-edge regenerative therapy, is available to comment on the treatments [...]

Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference

28/08/2024 - 23:00

IRVINE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients [...]

Foundation for Sarcoidosis Research Expands Scientific Advisory Board with 14 New Experts to Enhance Sarcoidosis Research and Patient Care

28/08/2024 - 22:48

CHICAGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, [...]

Celularity Appoints Richard J. Berman to its Board of Directors

28/08/2024 - 22:45

Seasoned Public Company Director and Finance Veteran Brings Extensive Track Record of Success in Facilitating the Growth of Shareholder Value FLORHAM PARK, N.J., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq [...]

Spectral AI to Participate in Upcoming Investor Conferences

28/08/2024 - 22:30

DALLAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]

iTeos to Participate in Upcoming Investor Conferences

28/08/2024 - 22:30

WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 28, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new [...]

Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

28/08/2024 - 22:15

ROCKVILLE, Md., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]

CooperCompanies Announces Third Quarter 2024 Results

28/08/2024 - 22:15

SAN RAMON, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2024. Revenue [...]

Akero Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

28/08/2024 - 22:05

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked [...]

Lyell Immunopharma Announces Participation in September Investor Conferences

28/08/2024 - 22:05

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with [...]

Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

28/08/2024 - 22:05

WEST LAFAYETTE, Ind., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and [...]